MedTrace Logo

Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)

NCT03861884 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2024-03-21

No results posted yet for this study

Summary

This prospective study aims:

1. to compare cognitive performance in different clinical groups of participants with mild cognitive impairment (MCI) or mild dementia \[Alzheimer's Disease (AD), Vascular Cognitive Impairment (VCI) and Fronto-temporal Dementia (FTD)\] to determine whether scores reveal differential profiles between the groups,
2. to demonstrate differences in imaging markers between different dementia syndromes and healthy volunteers using ultra high-field MRI at 7T.

Conditions

  • Dementia (Diagnosis)

Interventions

DIAGNOSTIC_TEST

Cognitive assessments

Cognitive assessment and MRI at 3T and/or 7T

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03861884 on ClinicalTrials.gov